Search research articles
Contact Us
Filters
Showing results (181-190 of 246) with videos related to
Page
of 25
Sort By:
Acta Neuropathologica Communications
|
January 20, 2025
A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis
Maria A Gubbiotti, Ian E McCutcheon, Priya Rao, et al.
Biorxiv : the Preprint Server for Biology
|
May 18, 2026
CXCL13-CXCR5 Signaling in CD8⁺ T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell Carcinoma
Daniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.
Cancer Immunology, Immunotherapy : CII
|
July 7, 2026
CXCL13-CXCR5 signaling in CD8<sup>+</sup> T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma
Daniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Alexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
JCO Clinical Cancer Informatics
|
May 1, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
BJU International
|
July 6, 2021
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation
Brian De, Aradhana M Venkatesan, Pavlos Msaouel, et al.
Urologic Oncology
|
November 14, 2020
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
Jad Chahoud, Pavlos Msaouel, Jeremy A Ross, et al.
Journal for Immunotherapy of Cancer
|
July 30, 2021
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, et al.
JCO Oncology Practice
|
November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy
Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 246) with videos related to
Sort By:
Page
of 25
Acta Neuropathologica Communications
|
January 20, 2025
A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis
Maria A Gubbiotti, Ian E McCutcheon, Priya Rao, et al.
Biorxiv : the Preprint Server for Biology
|
May 18, 2026
CXCL13-CXCR5 Signaling in CD8⁺ T Cell Recruitment and Lymphoid Immune Organization in Clear Cell Renal Cell Carcinoma
Daniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.
Cancer Immunology, Immunotherapy : CII
|
July 7, 2026
CXCL13-CXCR5 signaling in CD8<sup>+</sup> T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma
Daniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 12, 2023
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy
Alexander D Sherry, Pavlos Msaouel, Zachary R McCaw, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 7, 2024
Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
JCO Clinical Cancer Informatics
|
May 1, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials
Alexander D Sherry, Pavlos Msaouel, Gabrielle S Kupferman, et al.
BJU International
|
July 6, 2021
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation
Brian De, Aradhana M Venkatesan, Pavlos Msaouel, et al.
Urologic Oncology
|
November 14, 2020
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
Jad Chahoud, Pavlos Msaouel, Jeremy A Ross, et al.
Journal for Immunotherapy of Cancer
|
July 30, 2021
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events
Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, et al.
JCO Oncology Practice
|
November 7, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy
Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida, et al.
Page
of 25